Loading company…
Sistemic develops microRNA and molecular diagnostic assays for cell therapy characterization and related research.
Sistemic develops bespoke microRNA and molecular diagnostic assays for cell therapy characterization, quality control, toxicology, and drug response monitoring. Its customers include pharmaceutical and biotechnology companies working in stem cell therapy, gene therapy, and drug discovery. Based in Glasgow, UK, the company raised USD 1.00 mn in Series A funding on March 17, 2010, led by Scottish Enterprise and ChimeraBio.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in